Cost-effectiveness of oral versus injectable disease modifying therapies in relapsing multiple sclerosis: a systematic review analysis
Abstract Background Multiple sclerosis (MS) is a chronic and progressive neurological autoimmune disease that affects the central nervous system. There are two types of drugs used to treat this disease: injectable and oral drugs. The present study aimed at systematically reviewing the cost effective...
Saved in:
| Main Authors: | Mehdi Rezaee, Ramin Ravangard, Seyyed Morteza Mojtabaeian, Abdosaleh Jafari |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-10-01
|
| Series: | BMC Health Services Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12913-024-11800-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES
by: N. Z. Musina, et al.
Published: (2017-05-01) -
An Estimation of Cost-Effectiveness Threshold: Calculating the Monetary Value of a Quality-Adjusted Life Year
by: Samira Nourifard, et al.
Published: (2025-03-01) -
Extracorporeal carbon dioxide removal compared to ventilation alone in patients with acute hypoxaemic respiratory failure: cost-utility analysis of the REST RCT
by: Ashley Agus, et al.
Published: (2023-08-01) -
Pharmacoeconomic analysis of the use of tocilizumab in therapy for rheumatoid arthritis:imitation simulation
by: Dmitry Vladimirovich Goryachev, et al.
Published: (2010-04-01) -
Quality of life and growth hormone deficiency in adult patients in clinical evaluation and health economic assessment
by: Maria Kołtowska-Häggström
Published: (2009-09-01)